Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy.
Department of Pediatrics, Seattle Children's Hospital/University of Washington School of Medicine.
Whitney E
WE
Harrington
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
Michal
M
Fried
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
Patrick E
PE
Duffy
D004094:Dihydropteroate Synthase / Q000235:genetics*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000517:prevention & control*; D020125:Mutation, Missense; D010963:Plasmodium falciparum / Q000201:enzymology*; D011247:Pregnancy; D011739:Pyrimethamine / Q000494:pharmacology* / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000494:pharmacology* / Q000627:therapeutic use*
D013413:Sulfadoxine; D004094:Dihydropteroate Synthase; D011739:Pyrimethamine